February 11, 2016 – Stryker Corporation (NYSE:SYK) has announced the completion of its acquisition of imorphics, a company that specialises in the automated analysis of leading-edge 3 dimensional medical images.

Stryker is one of the world’s leading medical technology companies and is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing patient care. The Company offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products to help people lead more active and satisfying lives.

imorphics is a vanguard of 3D modelling technology and the identification of tissue with sub-voxel accuracy through automated segmentation.  Their proficiency in the fields of surgery, field studies and clinical trials makes it a logical acquisition by Stryker. Their expertise in the creation and automated analysis of 3D medical imaging is expected to complement Stryker’s commitment to innovation in joint reconstruction technology, adding real value to the organization and its shareholders.

For more information about Stryker, please visit



For media inquiries please contact:

For investor inquiries please contact:

Request details

If you would like to receive information about our products, or our company, please complete the form below and we will send our information pack to you.